Australia markets closed

Bioxyne Limited (BXN.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0080+0.0010 (+14.29%)
At close: 03:56PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
5,161
5,161
2,416
2,110
2,259
Cost of revenue
3,262
3,262
1,128
1,029
1,044
Gross profit
1,898
1,898
1,289
1,081
1,215
Operating expenses
Research development
-
-
-
89.726
130.243
Selling general and administrative
2,430
2,430
904.719
870.206
921.893
Total operating expenses
4,037
4,037
1,546
1,467
1,729
Operating income or loss
-2,139
-2,139
-257.62
-385.368
-514.196
Interest expense
7.032
-
0.582
1.684
7.032
Total other income/expenses net
85.137
85.137
-43.755
-94.703
-111.934
Income before tax
-1,964
-1,964
-236.508
-425.725
-593.095
Income tax expense
0
0
0
0
0
Income from continuing operations
-1,964
-1,964
-236.508
-425.725
-593.095
Net income
-1,964
-1,964
-236.508
-425.725
-593.095
Net income available to common shareholders
-1,964
-1,964
-236.508
-425.725
-593.095
Basic EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Diluted EPS
-0.00
-0.00
-0.00
-0.00
-0.00
Basic average shares
1,344,132
1,344,132
640,145
640,145
640,145
Diluted average shares
1,344,132
1,344,132
640,145
640,145
640,145